INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

269 studies · page 5 of 12

2015 / Narrative review

Dietary interventions and dietary components can modify the composition and metabolic products of the human gut microbiota.

This review summarizes the effects of diet, particularly dietary interventions, on the human gut microbiota. Controlled dietary shifts, including high-protein diets, high-fat diets, prebiotics, probiotics, and polyphenols, alter selected bacterial groups. Additionally, the type and quantity of non-digestible carbohydrates influence faecal bacterial populations and metabolic products formed in the lower gastrointestinal tract. Methodological and intrinsic human confounding factors regarding gut microbiota analyses are also discussed.

Maukonen J, Saarela M Proc Nutr Soc, 2015. PMID 25156389

2015 / Narrative review

Evidence suggests vitamin D may modify immune responses in IBD, with emerging trial data hinting at longer remission periods.

This review evaluates scientific evidence regarding vitamin D and inflammation, focusing primarily on inflammatory bowel disease (IBD). Suboptimal vitamin D status is common in IBD, and some studies suggest it associates with more severe disease. Early data from randomized controlled trials suggest that people with IBD may remain in remission longer when treated with oral vitamin D, though large, well-designed clinical trials are still needed.

O'Sullivan M Proc Nutr Soc, 2015. PMID 25490986

2015 / Narrative review

A review suggests 25(OH)D levels of ≥75 nmol/l may be needed for non-skeletal effects in Crohn's disease, but further research is needed.

This review examined the potential roles and optimal levels of vitamin D in patients with Crohn's disease. Multiple factors contribute to vitamin D deficiency in this population, including inadequate dietary intake and sunlight, impaired conversion, increased catabolism or excretion, and genetic variants. Emerging evidence suggests vitamin D may play roles in immunity, reducing disease severity, preventing hospitalizations or surgery, and preventing colon cancer. The literature suggests serum 25(OH)D concentrations of ≥75 nmol/l may be required for non-skeletal outcomes, though further research is required.

Raftery T, O'Sullivan M Proc Nutr Soc, 2015. PMID 25497215

2015 / Narrative review

Dietary factors including fiber, calcium, red meat, and processed meat are linked to colorectal cancer risk.

Extensive epidemiologic and experimental studies highlight the role of diet in colorectal cancer risk. Calcium, fiber, milk, and whole grains have been associated with a lower risk, whereas red and processed meats have been linked to an increased risk. Evidence also supports potential chemopreventive effects of vitamin D, folate, fruits, and vegetables, with mechanisms likely involving inflammation, immune response, obesity, and the gut microbiota.

Shows an association, not proof of cause and effect.

Song M, Garrett WS, Chan AT Gastroenterology, 2015. PMID 25575572

2015 / Narrative review

Short-term microbiome interventions may only have transient effects in inflammatory bowel disease as the adult microbiome tends to revert post-treatment.

Inflammatory bowel disease encompasses chronic conditions driven by excessive gastrointestinal inflammation, with the gut microbiome playing a critical role in its pathogenesis. This review examined therapies aimed at manipulating the microbiome, including diet, pre- and probiotics, antibiotics, and fecal microbiota transplant. Current literature indicates that the adult microbiome is highly resilient to short-term interventions, triggering rapid changes that typically revert to pre-treatment states once therapy concludes. Consequently, short-term manipulation of the human microbiome may produce only transient therapeutic effects.

Berg D, Clemente JC, Colombel JF Expert Rev Gastroenterol Hepatol, 2015. PMID 25665875

2015 / Narrative review

Dietary components may reduce Helicobacter pylori colonization levels and virulence without complete eradication.

This review examines dietary components used to treat and/or prevent Helicobacter pylori infection, focusing on work from the prior decade with mechanism-based plausibility and clinical results. Evidence indicates diet-based treatments may reduce H pylori colonization levels or virulence without completely eradicating the organism. Highlighted categories include bee products, probiotics, dairy products, vegetables, fruits, oils, essential oils, and herbs, spices, and other plants. The authors state that the available preclinical evidence must be followed up with rationally designed, unambiguous human trials.

Fahey JW, Stephenson KK, Wallace AJ Nutr Res, 2015. PMID 25799054

2015 / Commentary / narrative review

A commentary discusses findings that non-caloric artificial sweeteners may induce glucose intolerance by altering the gut microbiome.

Non-caloric artificial sweeteners (NAS) are widely consumed to combat weight gain and diabetes, but their role in promoting metabolic derangements remains controversial. The authors recently demonstrated that NAS consumption can induce glucose intolerance in mice and distinct human subsets through functional alterations of the gut microbiome. This commentary reviews these findings alongside other works and outlines the challenges in understanding how NAS impacts human health.

Suez J, Korem T, Zilberman-Schapira G, et al. Gut Microbes, 2015. PMID 25831243

2015 / Review

Dietary modification focusing on specific nutrients, foods, and gut microbiota impacts may aid in preventing and managing atherosclerosis.

This narrative review examines the role of diet in the prevention and complementary clinical management of atherosclerosis. It discusses evidence and mechanisms for specific nutrients and foods, including fiber, plant sterols/stanols, niacin, taurine, olive oil, omega-3 fatty acids, antioxidants, minerals, methyl nutrients, and soy. It also highlights that intestinal microbiota dysbiosis associated with certain animal food sources can generate metabolites involved in atherosclerosis development.

Torres N, Guevara-Cruz M, Velázquez-Villegas LA, et al. Arch Med Res, 2015. PMID 26031780

2015 / Narrative review

A review indicates individuals with autism show significant intestinal microbiome differences, including increased clostridial species, compared to controls.

This review examined published literature evaluating the intestinal microbiota in individuals with autism. Studies reported significant differences in the microbiome of patients with autism compared with unaffected controls, including several reports of increased clostridial species. Alterations in the microbiome, potentially influenced by environmental factors, may contribute to autism via altered immune function and bacterial metabolites, and proposed interventions to modify microbial imbalances were discussed.

Shows an association, not proof of cause and effect.

Buie T Clin Ther, 2015. PMID 26046240

2015 / Narrative review

Evidence suggests non-nutritive sweeteners have metabolic effects and may promote metabolic dysregulation through multiple mechanisms.

This review summarizes scientific evidence regarding potential mechanisms by which non-nutritive sweeteners (NNSs) might promote metabolic dysregulation. Epidemiological studies link NNS consumption, primarily from diet sodas, with increased risk for obesity, metabolic syndrome, and type 2 diabetes. Proposed mechanisms include interference with learned responses controlling glucose and energy homeostasis, disruption of gut microbiota inducing glucose intolerance, and interaction with sweet-taste receptors in the digestive tract. Laboratory findings also demonstrate an association between individual taste sensitivity to sucralose and acute metabolic responses to an oral glucose load.

Shows an association, not proof of cause and effect.

Pepino MY Physiol Behav, 2015. PMID 26095119

2015 / Narrative review

A review discusses diet, gut microbiota-derived TMAO, and cardiovascular concerns in nondialysis chronic kidney disease patients.

This narrative review examines dietary factors, gut microbiota, and the uremic toxin trimethylamine N-oxide (TMAO) in patients with nondialysis chronic kidney disease (CKD). Low-protein diets are recommended in this population because excess protein can harm kidney function and generate uremic toxins. TMAO, a degradation product of choline and L-carnitine derived primarily from animal protein such as red meat and eggs, is considered a proatherogenic metabolite with potential cardiovascular implications in CKD.

Moraes C, Fouque D, Amaral AC, et al. J Ren Nutr, 2015. PMID 26235933

2015 / Narrative review and metagenomic database analysis

Gut microbiota trimethylamine (TMA) production potential was associated with symptomatic atherosclerosis in public metagenomic data sets.

The authors reviewed literature on gut microbiota-derived trimethylamine (TMA), a metabolite linked to atherosclerosis development, to demonstrate big data integration workflows. By translating elucidated microbial pathways for TMA production into genomic orthologs, public (meta-)genomic databases were mined and linked to metadata. Reviewing pathway abundance showed that TMA production potential is associated with symptomatic atherosclerosis and facilitated identification of previously uncharacterized TMA-producing bacteria.

Shows an association, not proof of cause and effect.

Falony G, Vieira-Silva S, Raes J Annu Rev Microbiol, 2015. PMID 26274026

2015 / Historical narrative review

A review outlines how genetics, processing, and microbiota helped humans overcome lactose intolerance and notes food labeling might help manage intake.

This review analyzes the expansion of the modern dairy industry alongside the drawback of widespread lactose intolerance. Over centuries, humans overcame limitations through genetic mutations in specific populations, development of low-lactose products like cheese and yogurt, and colon microbiome adaptation. Because some modern dairy products and non-dairy items contain lactose, the authors conclude that it might be important and helpful to label foods containing lactose so individuals can control intake within the physiological limitation of ~12 g per single meal.

Silanikove N, Leitner G, Merin U Nutrients, 2015. PMID 26404364

2015 / Clinical review

Gastroesophageal reflux in infants and youth can be managed with feeding, diet, and lifestyle adjustments alongside medications when necessary.

Gastroesophageal reflux is a normal physiologic process, whereas GERD causes troublesome symptoms or complications. Diagnoses rely on history and physical examination, with specialized testing reserved for atypical symptoms or suspected complications. In infants, management options include positioning changes while awake, lower-volume feedings, thickening agents like rice cereal, antiregurgitant or hydrolyzed formulas, and maternal elimination of cow's milk and eggs in breastfed infants. For children and adolescents, lifestyle recommendations include sleep position changes, weight loss, and avoiding alcohol, smoking, and late evening meals.

Baird DC, Harker DJ, Karmes AS Am Fam Physician, 2015. PMID 26554410

2014 / Narrative review of patient-targeted dietary recommendations

Patient-targeted dietary recommendations for inflammatory bowel disease focus heavily on food restrictions and are highly conflicting.

This review aimed to identify patient-targeted dietary recommendations for inflammatory bowel disease (IBD) and appraise their nutritional value. The authors reviewed patient-targeted dietary information gathered from structured Internet searches and popular defined diets. They found that these recommendations focus largely on food restrictions and are highly conflicting. The authors note that data showing dietary changes can alter the natural history of IBD are scarce, highlighting the need for high-quality dietary intervention studies.

Hou JK, Lee D, Lewis J Clin Gastroenterol Hepatol, 2014. PMID 24107394

2014 / Narrative review

A review notes limited evidence for pediatric GERD management and cautions against simultaneous overdiagnosis of GERD and cow's milk protein allergy.

Researchers reviewed literature up to May 2013 across multiple databases to assess scientific evidence for pediatric GERD diagnosis and treatment. The review found that simultaneous treatment of GERD and cow's milk protein allergy often leads to unnecessary medication or elimination diets. In addition, abdominal ultrasonography should not be recommended for investigating GER, and there is little evidence supporting acid suppression in the first year of life for nonspecific symptoms.

Ferreira CT, Carvalho Ed, Sdepanian VL, et al. J Pediatr (Rio J), 2014. PMID 24184302

2014 / Narrative review

The intestinal microbiome is a potential therapeutic target in the development and treatment of cardio-metabolic diseases.

Recent studies suggest a potential role for intestinal microbes in the expression of certain human cardio-metabolic diseases. Mechanisms through which gut microbiota and their metabolic products affect systemic homeostasis and cardio-metabolic risks are beginning to be uncovered. Human intervention studies focused on altering microbial composition or pharmacologically manipulating microbiota to influence metabolite production are needed next steps.

Vinjé S, Stroes E, Nieuwdorp M, et al. Eur Heart J, 2014. PMID 24216389

2014 / Narrative review

A review reports that dietary factors, the microbiome, and lifestyle changes modestly influence nonalcoholic fatty liver disease.

This review evaluates recent research on how diet, nutrients, and the microbiome contribute to nonalcoholic fatty liver disease (NAFLD). The authors note that fructose appears to be associated with NAFLD severity, while several studies demonstrate that the Mediterranean diet and 'lifestyle change' are effective in modestly improving NAFLD. A study in children reported simultaneous improvements in cardiovascular disease risk measurements and hepatic steatosis. The review concludes that current data supports limiting sugar in the diet and 'lifestyle change' as a first-line treatment for NAFLD, with modest observed benefits.

Vos MB Curr Opin Lipidol, 2014. PMID 24366230

2014 / Narrative review

Dietary modulation of gut microbiota via whole-plant foods, prebiotics, and probiotics may help manage cardiovascular risk.

This review summarizes evidence connecting gut microbiome activities with cardiovascular disease (CVD) and dietary modulation. Aberrant gut microbiota profiles are linked to obesity, diabetes, and non-alcoholic fatty liver disease, while microbial metabolites from choline, phosphatidylcholine, and l-carnitine directly contribute to CVD pathology. In human studies, selected bile-salt hydrolysing probiotic strains lowered blood cholesterol, and fermentable fibers and plant polyphenols appear to regulate microbial activities. The review concludes that dietary strategies modulating gut microbiota are emerging as efficacious tools for reducing CVD risk, suggesting the way to a healthy heart may be through a healthy gut.

Tuohy KM, Fava F, Viola R Proc Nutr Soc, 2014. PMID 24495527

2014 / Narrative review

A review describes how diet influences the intestinal microbiome structure and metabolome, with potential implications for health and disease.

This review examines the mutual relationship between diet and the intestinal microbiota in mammalian hosts. It highlights that nutrient consumption influences microbial community structure and provides substrates for microbial metabolism, generating small molecules that affect host physiological processes. It notes diet-related microbial differences, such as in breastfed versus formula-fed infants and agrarian plant-based versus meat- and fat-rich Western diets, and discusses implications for conditions like coronary vascular disease and inflammatory bowel disease.

Shows an association, not proof of cause and effect.

Albenberg LG, Wu GD Gastroenterology, 2014. PMID 24503132

2014 / Narrative review

Risk factors for gastroesophageal reflux disease include obesity, poor diet, lack of physical activity, alcohol, tobacco, and respiratory diseases.

This review summarizes the epidemiology, complications, healthcare costs, and risk factors of gastroesophageal reflux disease (GERD). The prevalence of GERD symptoms rose approximately 50% until the mid-1990s before plateauing, alongside shifting trends in complications like esophageal adenocarcinoma and strictures. Reported risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.

Shows an association, not proof of cause and effect.

Rubenstein JH, Chen JW Gastroenterol Clin North Am, 2014. PMID 24503355

2014 / Narrative review

Intestinal microbiota and fecal transplantation are implicated in regulating human glucose and lipid metabolism in insulin resistance and type 2 diabetes.

This review examines the role of intestinal microbiota and fecal transplantation in insulin resistance and type 2 diabetes mellitus. Alterations in intestinal microbiota composition promote systemic inflammation, which is a hallmark of obesity and subsequent insulin resistance. Fecal transplantation studies indicate that butyrate-producing intestinal bacteria are crucial key players in regulating diverse signaling cascades linked to human glucose and lipid metabolism.

Udayappan SD, Hartstra AV, Dallinga-Thie GM, et al. Clin Exp Immunol, 2014. PMID 24528224

2014 / Narrative review

A macrobiotic Ma-Pi 2 diet and prebiotic-rich diets may help manage type 2 diabetes by modulating gut microbiota.

This review discusses the influence of diet, gut microbiota, and inflammation on type 2 diabetes mellitus (T2DM). High-fat diets can promote dysbiosis and inflammation, whereas prebiotics may reduce inflammation, improve insulin resistance, and regulate appetite hormones. A recent 21-day intervention study in T2DM patients reported that the macrobiotic Ma-Pi 2 diet significantly improved fasting blood glucose, plasma lipid fractions, plasma insulin, and homeostasis. The authors note that these effects must be confirmed in larger randomized controlled trials evaluating indicators of inflammation.

Fallucca F, Porrata C, Fallucca S, et al. Diabetes Metab Res Rev, 2014. PMID 24532292